S. Ferraro

发表

Optimizing the identification of risk‐relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families

I. Screpanti, G. Giannini, L. Ottini, 2017, Cancer medicine.

Characterization of medulloblastoma in Fanconi Anemia: a novel mutation in the BRCA2 gene and SHH molecular subgroup

I. Screpanti, G. Giannini, E. Miele, 2015, Biomarker Research.

Novel and recurrent BRCA2 mutations in Italian breast/ovarian cancer families widen the ovarian cancer cluster region boundaries to exons 13 and 14

I. Screpanti, G. Giannini, A. Gulino, 2014, Breast Cancer Research and Treatment.

Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancer.

I. Screpanti, G. Giannini, A. Gulino, 2015, Clinical biochemistry.

Coexistence of three EGFR mutations in an NSCLC patient: A brief report

G. Giannini, C. Nicolazzo, A. Gradilone, 2018, The International journal of biological markers.

Beneficial Metabolic Effect of a Nutraceuticals Combination (Monacolin K, Yeasted Red Rice, Polyphenolic Extract of Annurca Apple and Berberine) on Acquired Hypercholesterolemia: A Prospective Analysis

R. D'Assante, A. Cittadini, F. Natale, 2021, Metabolites.

Peer Review #2 of "Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer (v0.1)"

G. Giannini, C. Capalbo, M. Petroni, 2019 .

Does the search for large genomic rearrangements impact BRCAPRO carrier prediction?

I. Screpanti, G. Giannini, E. Ricevuto, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families

I. Screpanti, G. Giannini, E. Ricevuto, 2006, Breast Cancer Research and Treatment.

Clinical classification of BRCA1 DNA missense variants: H1686Q is a novel pathogenic mutation occurring in the ontogenetically invariant THV motif of the N-terminal BRCT domain.

I. Screpanti, G. Giannini, E. Ricevuto, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Identification of novel BRCA1 large genomic rearrangements by a computational algorithm of amplicon-based Next-Generation Sequencing data

G. Giannini, L. Ottini, C. Capalbo, 2019, PeerJ.

Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer

G. Giannini, L. Ottini, C. Capalbo, 2019, PeerJ.

Improving the accuracy of BRCA1/2 mutation prediction: validation of the novel country-customized IC software

I. Screpanti, G. Giannini, E. Ricevuto, 2006, European Journal of Human Genetics.

Intratumoral heterogeneity in colorectal carcinoma: trucut sampling for DNA ploidy analysis.

A. Vecchione, M. Giovagnoli, S. Ferraro, 1999, Anticancer research.

Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer families

I. Screpanti, G. Giannini, E. Ricevuto, 2007, Breast Cancer Research and Treatment.

BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models.

A Gulino, I. Screpanti, G. Giannini, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Characterization of medulloblastoma in Fanconi Anemia: a novel mutation in the BRCA2 gene and SHH molecular subgroup

I. Screpanti, G. Giannini, E. Miele, 2015, Biomarker Research.